Qatar Cardiometabolic Cohort
ConditionCardiometabolic Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWeill Cornell Medical College in Qatar
About this trial
Our objective is to create a cardiometabolic cohort that could be representative of the local population, consisting of Qataris and long-term residents, in order to identify the prevalence, risk factors, and clinical characteristics of cardiometabolic disorders, as well as the incidence of atherosclerotic cardiovascular disease events.
Eligibility criteria
Qualifiers
Qataris
Long-term residents (≥15 years of residence in Doha) who are not planning to leave Qatar voluntarily within the next 5 years.
Age ≥18 years.
English or Arabic speaker.
Disqualifiers
Type 1 diabetes or monogenic diabetes (e.g., MODY).
Pregnancy (self-reported).
Active cancer, under medical or radiation therapy or terminal, or cancer in remission < 1 year.
Chronic immune or chronic infectious diseases.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
3,000 Participants
are grouped into 3 trial groupsSponsors and collaborators
Weill Cornell Medical College in Qatar
Lead sponsor
Hamad Medical Corporation
Collaborator
Source ClinicalTrials.gov